MilliporeSigma:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:MilliporeSigma - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7132
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MilliporeSigma, formerly Sigma-Aldrich Corp, a subsidiary of Merck KGaA is a life sciences and technology company which offers biochemical and organic chemical products, kits and services. Its products and services find application in scientific research including genomic and proteomic research; diagnosis of diseases; pharmaceutical development and biotechnology sectors. The company offers its solutions to hospitals, biotechnology and pharmaceutical companies, commercial laboratories, universities, industrial companies, governmental institutions, non-profit organizations, diagnostic, and chemical and electronics companies. It operates across the Americas, Asia-Pacific, Europe, the Middle East and Africa. MilliporeSigma is headquartered in St. Louis, Missouri, the US.

MilliporeSigma – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MilliporeSigma, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MilliporeSigma, Medical Equipment Deals By Type, 2012 to YTD 2018 6
MilliporeSigma, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MilliporeSigma, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
MilliporeSigma, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
MilliporeSigma, Medical Equipment, Deal Details 10
Asset Purchase 10
Sigma-Aldrich Acquires Duolink Product Portfolio from Olink Bioscience 10
Partnerships 11
MilliporeSigma Enters into Distribution Agreement with HistoCyte Labs 11
Sigma-Aldrich Enters into Distribution Agreement with LGC 12
Sigma-Aldrich and GenapSys to Co-Market Genius system 13
Sigma-Aldrich Enters Into Distribution Agreement With Biomatrica For Biospecimen Storage Products 14
GE Healthcare Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich 15
Sigma Life Science Enters Into Distribution Agreement With Olink Bioscience For Duolink Technology 16
Sage Labs Enters Into Agreement With Ekam Imaging To Develop Imaging Assays 17
SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor 18
Little Things Factory Enters Into Distribution Agreement With Sigma-Aldrich For Microreactors 19
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 20
Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 21
Asset Transactions 22
Honeywell International Acquires Research Chemicals Business from Sigma-Aldrich 22
Acquisition 24
Merck Acquires Sigma-Aldrich for USD17 Billion 24
Sigma-Aldrich Acquires Cell Marque 26
MilliporeSigma – Key Competitors 27
MilliporeSigma – Key Employees 28
MilliporeSigma – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Joint Venture 29
Recent Developments 30
Strategy And Business Planning 30
May 12, 2017: MilliporeSigma and Stelis Biopharma Open First Joint Bioprocess Scale-up Lab in India 30
Product News 31
May 29, 2018: MilliporeSigma Announces Collaboration with Solvias for New Pyrogen Detection Kit 31
Apr 04, 2018: MilliporeSigma to Launch New Flow Cytometer, Host CellStream Workshop at CYTO 2018 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
MilliporeSigma, Medical Equipment, Key Facts 2
MilliporeSigma, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
MilliporeSigma, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MilliporeSigma, Medical Equipment Deals By Type, 2012 to YTD 2018 6
MilliporeSigma, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MilliporeSigma, Deals By Market, 2012 to YTD 2018 8
MilliporeSigma, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sigma-Aldrich Acquires Duolink Product Portfolio from Olink Bioscience 10
MilliporeSigma Enters into Distribution Agreement with HistoCyte Labs 11
Sigma-Aldrich Enters into Distribution Agreement with LGC 12
Sigma-Aldrich and GenapSys to Co-Market Genius system 13
Sigma-Aldrich Enters Into Distribution Agreement With Biomatrica For Biospecimen Storage Products 14
GE Healthcare Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich 15
Sigma Life Science Enters Into Distribution Agreement With Olink Bioscience For Duolink Technology 16
Sage Labs Enters Into Agreement With Ekam Imaging To Develop Imaging Assays 17
SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor 18
Little Things Factory Enters Into Distribution Agreement With Sigma-Aldrich For Microreactors 19
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 20
Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 21
Honeywell International Acquires Research Chemicals Business from Sigma-Aldrich 22
Merck Acquires Sigma-Aldrich for USD17 Billion 24
Sigma-Aldrich Acquires Cell Marque 26
MilliporeSigma, Key Competitors 27
MilliporeSigma, Key Employees 28
MilliporeSigma, Subsidiaries 29
MilliporeSigma, Joint Venture 29

List of Figures
MilliporeSigma, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
MilliporeSigma, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
MilliporeSigma, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
MilliporeSigma, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
MilliporeSigma, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MilliporeSigma, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
MilliporeSigma, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MilliporeSigma, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[MilliporeSigma:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Globe Telecom, Inc.:企業の戦略・SWOT・財務情報
    Globe Telecom, Inc. - Strategy, SWOT and Corporate Finance Report Summary Globe Telecom, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Clevexel Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Clevexel Pharma SAS (Clevexel) is a pharmaceutical company that develops drugs for the treatment of central nervous system diseases. The company’s pipeline product candidate includes CVXL-0107, a glutamate release inhibitor developed to improve the quality of life for Parkinson’s disease pat …
  • aTyr Pharma Inc (LIFE):企業の財務・戦略的SWOT分析
    Summary ATyr Pharma Inc (ATyr Pharma) is a clinical-stage biotechnology company engaged in the discovery and clinical development of medicines for the treatment of cancer and lung diseases. The company’s ATYR1923 is a clinical-stage product candidate, based on the resokine pathway, which binds to th …
  • Kallpa Generacion SA:企業の戦略的SWOT分析
    Kallpa Generacion SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Life Time Inc:企業の戦略的SWOT分析
    Life Time Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • CASIO COMPUTER CO., LTD.:企業の戦略・SWOT・財務情報
    CASIO COMPUTER CO., LTD. - Strategy, SWOT and Corporate Finance Report Summary CASIO COMPUTER CO., LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Wistron Corporation:企業の戦略・SWOT・財務情報
    Wistron Corporation - Strategy, SWOT and Corporate Finance Report Summary Wistron Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Mevion Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Mevion Medical Systems Inc (Mevion), formerly Still River Systems is a medical equipment company that offers therapy systems. The company offers radiation therapy and proton therapy systems for the treatment of cancer. It provides MEVION S250 proton therapy system designed for preserving tre …
  • SunPower Corp (SPWR):企業の財務・戦略的SWOT分析
    SunPower Corp (SPWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • PNM Resources, Inc. (PNM):電力:M&Aディール及び事業提携情報
    Summary PNM Resources, Inc. (PNMR) is an energy holding company. Through its utilities PNM and TNMP, the company generates, transmits, and distributes electricity; and transports natural gas. It produces electricity from coal, natural gas, nuclear, solar, wind, and geothermal sources. Through long-t …
  • Atriva Therapeutics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Atriva Therapeutics GmbH (Atriva Therapeutics) is a developer of antiviral therapies that develops therapies against seasonal and pandemic influenza. The company develops ATR-001 drug candidate, a MEK inhibitor which targets influenza. It also offers repurposing existing MEK inhibitors, orig …
  • Swissport International Ltd.:企業の戦略・SWOT・財務情報
    Swissport International Ltd. - Strategy, SWOT and Corporate Finance Report Summary Swissport International Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Hutchison China Meditech Ltd:企業の戦略・SWOT・財務分析
    Hutchison China Meditech Ltd - Strategy, SWOT and Corporate Finance Report Summary Hutchison China Meditech Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Multan Electric Power Company:企業の戦略的SWOT分析
    Multan Electric Power Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • St. Joseph Health:企業の戦略的SWOT分析
    St. Joseph Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Hamilton Thorne Ltd (HTL):企業の財務・戦略的SWOT分析
    Summary Hamilton Thorne Ltd (Hamilton Thorne) operates as a medical equipment company that offers precision laser devices and advanced image analysis systems. The company's products include clinical lasers, animal and research sperm analysis products, research lasers, clinical sperm analysis product …
  • Puretech Health plc (PRTC):企業の財務・戦略的SWOT分析
    Summary Puretech Health Plc (Puretech), formerly PureTech Ventures LLC, is a biopharmaceutical company that develops medicines for diseases caused by dysfunction in the nervous, gastrointestinal, and immune systems. The company develops a microbiome immune system drug-discovery platform and drug can …
  • Kaiser Permanente
    Kaiser Permanente - Strategy, SWOT and Corporate Finance Report Summary Kaiser Permanente - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Arix Bioscience PLC:企業のM&A・事業提携・投資動向
    Arix Bioscience PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Arix Bioscience PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Lung Biotechnology PBC:製薬・医療:M&Aディール及び事業提携情報
    Summary Lung Biotechnology PBC (LBI), formerly Lung Biotechnology Inc, is a subsidiary of United Therapeutics Corp, is a biotechnology company that develops and commercializes new therapies for the treatment of PAH and other fatal lung diseases. The company provides product such as Adcirca and Tyvas …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆